MBX-SD-103

N/A

Report date: 2025/01/26 16:08:21

Base Information

Drug NameMBX-SD-103
Drug Alias Namemicrobiome based therapy (Mybiotix)microbiome bsed therapy (Mybiotix/Rebiotix/Ferring Pharmaceuticals)MBX-SD-103
ClassificationBiologics
Mechanisms of ActionMicrobiome modulators
TargetsUpdating
Therapy Area/IndicationsVaginosis, Bacterial
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySwitzerlandIsrael
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesMybiotix Pharma Ltd
China Registration ClassN/A

Develop Information

Active CompaniesMybiotix Pharma LtdFerring Pharmaceuticals Sa
Inactive CompaniesN/A
Active IndicationsVaginosis, Bacterial
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A